REDHILL BIOPHARMA LTD's ticker is and the CUSIP is 757468903. A total of 3 filers reported holding REDHILL BIOPHARMA LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 2,800 | +2700.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -99.0% | 0.00% | – |
| Q1 2022 | $26,000 | -67.1% | 10,500 | -65.9% | 0.00% | – |
| Q4 2021 | $79,000 | -92.3% | 30,800 | -86.2% | 0.00% | -100.0% |
| Q3 2021 | $1,020,000 | +51.6% | 222,700 | +127.7% | 0.00% | 0.0% |
| Q2 2021 | $673,000 | -44.0% | 97,800 | -40.4% | 0.00% | -50.0% |
| Q1 2021 | $1,201,000 | +429.1% | 164,100 | +484.0% | 0.00% | – |
| Q4 2020 | $227,000 | +25.4% | 28,100 | +58.8% | 0.00% | -100.0% |
| Q3 2020 | $181,000 | +60.2% | 17,700 | +5.4% | 0.00% | 0.0% |
| Q2 2020 | $113,000 | +117.3% | 16,800 | +46.1% | 0.00% | – |
| Q1 2020 | $52,000 | -68.9% | 11,500 | -58.2% | 0.00% | -100.0% |
| Q4 2019 | $167,000 | +74.0% | 27,500 | +102.2% | 0.00% | 0.0% |
| Q3 2019 | $96,000 | +159.5% | 13,600 | +202.2% | 0.00% | – |
| Q1 2019 | $37,000 | +37.0% | 4,500 | -6.2% | 0.00% | – |
| Q4 2018 | $27,000 | -38.6% | 4,800 | -4.0% | 0.00% | – |
| Q3 2018 | $44,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |